logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SWIRE PACIFIC B(00087) spent 1.704 million Hong Kong dollars on November 14 to repurchase 165,000 shares.

date
18:43 14/11/2024
avatar
GMT Eight
The announcement made by Swire Pacific Limited B (00087) reveals that they spent 1.704 million Hong Kong dollars on November 14, 2024...
SWIRE PACIFIC B (00087) announced that on November 14, 2024, they spent 1.704 million Hong Kong dollars to repurchase 165,000 shares, at a repurchase price of 10.28-10.46 Hong Kong dollars per share.
Related Articles
HK Stock
In the first two months, the Metallurgical Corporation of China (01618) signed new contracts worth 132.44 billion yuan, a decrease of 6.49% compared to the same period last year.
HK Stock
BROAD HOMES (02163): Xie Yaping appointed as Chief Financial Officer.
China Stock
Shenyang Xingqi Pharmaceutical (300573.SZ): SQ-24071 eye drops phase I clinical trial first subject enrolled in the study.
In the first two months, the Metallurgical Corporation of China (01618) signed new contracts worth 132.44 billion yuan, a decrease of 6.49% compared to the same period last year.
HK Stock
BROAD HOMES (02163): Xie Yaping appointed as Chief Financial Officer.
HK Stock
Shenyang Xingqi Pharmaceutical (300573.SZ): SQ-24071 eye drops phase I clinical trial first subject enrolled in the study.
China Stock
RECOMMEND
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
icon
11/03/2026
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
icon
11/03/2026
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
icon
11/03/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.